Physician Assistant Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Christopher Adrig

Physician Assistant Seattle, WA Physician Assistant

NPI 1184606089 CMS profile 10875457

201 16Th Ave E, Seattle, WA 98112

Open in the dashboard

General payments

$1,176

88 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Christopher Adrig of Seattle, WA is reported in the CMS Open Payments database as having received $1,176 across 88 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 71st percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $230 20
2024 General $368 24
2023 General $364 29
2022 General $214 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christopher Adrig
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Christopher Adrig were reported at $230. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Christopher Adrig Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $0 $132 $37–$438 $132
2022 $214 $155 $48–$522 $149
2023 $364 $167 $52–$557 $160
2024 $368 $178 $55–$600 $164
2025 $230 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. AbbVie, Inc. $673 63 payments
  2. AstraZeneca Pharmaceuticals LP $177 4 payments
  3. Bayer HealthCare Pharmaceuticals Inc. $106 7 payments
  4. Otsuka America Pharmaceutical, Inc. $67 4 payments
  5. Salix Pharmaceuticals, a division of Bausch Health US, LLC $42 3 payments
  6. Lilly USA, LLC $33 2 payments
  7. Abbott Laboratories $21 1 payment
  8. Novo Nordisk Inc $15 1 payment
  9. Medtronic, Inc. $15 1 payment
  10. Amgen Inc. $14 1 payment
  11. Other $13 1 payment

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Food and Beverage $1,162 87 payments
  2. Education $14 1 payment
Products named General payments · program years 2022–2025
  1. UBRELVY $320 26 payments
  2. BREZTRI $140 2 payments
  3. VRAYLAR Neuroscience $139 14 payments
  4. VRAYLAR Neuroscience $138 16 payments
  5. FARXIGA $134 2 payments
  6. QULIPTA $126 13 payments
  7. AIRSUPRA $119 1 payment
  8. Kerendia $106 7 payments
  9. XIFAXAN $83 6 payments
  10. REXULTI $67 4 payments
  11. Other $132 8 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 92 drugs

Part D claims

3,682

Median for Physician Assistant: 241

Drug cost

$192,634

Median for Physician Assistant: $4,110

Branded share of claims

21.8%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Jardiance Empagliflozin Brand 42 $52,878
Eliquis Apixaban Brand 49 $38,775
Ozempic Semaglutide Brand 24 $22,738
Xarelto Rivaroxaban Brand 11 $13,321
Mounjaro Tirzepatide Brand 11 $11,568
Movantik Naloxegol Oxalate Brand 11 $4,499
Lantus Solostar Insulin Glargine,hum.Rec.Anlog Brand 32 $3,971
Atorvastatin Calcium Generic 277 $3,215
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 144 $2,283
Albuterol Sulfate Hfa Albuterol Sulfate Brand 63 $2,218

The 10 drugs with the highest cost, of 92 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 55 billing codes

Paid by Medicare

$69,995

Of which drugs: $19,046

Medicare patients

343

Average age 74

Services billed

6,339

146 women, 197 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 52%
Arthritis 34%
Atrial fibrillation 20%
Diabetes 16%
Ischemic heart disease 13%
Cancer 12%
Heart failure 10%
Chronic kidney disease 9%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 10 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
VRAYLAR
  • AbbVie, Inc. $84
$84 — —
BREZTRI
  • AstraZeneca Pharmaceuticals LP $61
$61 — —
FARXIGA
  • AstraZeneca Pharmaceuticals LP $55
$55 — —
QULIPTA
  • AbbVie, Inc. $50
$50 — —
AIRSUPRA
  • AstraZeneca Pharmaceuticals LP $40
$40 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 10 in the dashboard with a free account

Records

88 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Washington

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record